Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer.
about
Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis.Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinomaXRCC3 Thr241Met polymorphism and clinical outcomes of NSCLC patients receiving platinum-based chemotherapy: a systematic review and meta-analysisPredictive value of XPD polymorphisms on platinum-based chemotherapy in non-small cell lung cancer: a systematic review and meta-analysis.XRCC3 Thr241Met is associated with response to platinum-based chemotherapy but not survival in advanced non-small cell lung cancer.Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.Predictive effect of XRCC3 Thr241Met polymorphism on platinum-based chemotherapy in lung cancer patients: meta-analysis.The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.Pharmacogenomics of platinum-based chemotherapy sensitivity in NSCLC: toward precision medicine.Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems.Xeroderma pigmentosum complementation group D polymorphism toward lung cancer susceptibility survival and response in patients treated with platinum chemotherapy.
P2860
Q33912148-46C59DFD-CC27-4E30-A4FD-8627675E3054Q34549516-173BE231-F30A-4934-8A9A-971FD1EA6ABDQ34934491-DB2767A7-0073-4979-BE7D-368E4E46839AQ34973738-BE55A0EC-538C-4113-B8FF-7D1DE211F134Q35015020-27C36576-CA24-450E-BC01-62CF354A7489Q35048754-1E6D1987-4E3D-47B0-8203-CF3D2D5CFDA0Q38132728-45C27FE9-D4F5-43B9-8DC1-36372728D86FQ38171397-2DEEA8E0-1B98-46AC-9B6D-20F4E62B9960Q38909984-274035F1-800A-41A1-A361-453333930235Q38953629-4CFD34BB-151E-40F3-BB75-29AAC6CDB093Q47895685-2310ED43-F282-4EEE-BE1A-8AF2A95AF1D8
P2860
Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prospective assessment of XRCC ...... hisms in advanced lung cancer.
@en
Prospective assessment of XRCC ...... hisms in advanced lung cancer.
@nl
type
label
Prospective assessment of XRCC ...... hisms in advanced lung cancer.
@en
Prospective assessment of XRCC ...... hisms in advanced lung cancer.
@nl
prefLabel
Prospective assessment of XRCC ...... hisms in advanced lung cancer.
@en
Prospective assessment of XRCC ...... hisms in advanced lung cancer.
@nl
P2093
P2860
P1476
Prospective assessment of XRCC ...... hisms in advanced lung cancer.
@en
P2093
F Cardenal
J L Ramírez
J R Delgado
R De las Peñas
P2860
P2888
P304
P356
10.1007/S00280-012-1985-9
P577
2012-09-29T00:00:00Z